Biomarker DACT1 for gastric cancer

Biomarker DACT1 for gastric cancer

  • CN 103,627,785 A
  • Filed: 12/17/2012
  • Published: 03/12/2014
  • Est. Priority Date: 12/16/2011
  • Status: Active Application
First Claim
Patent Images

1. the method that detects individual cancer of the stomach, it comprises the following steps:

  • (a) measure the expression level of DACT1 in the sample of taking from described individuality;

    And(b) expression level and the standard control that in step (a), obtain are compared,While wherein comparing with standard control, the decline of DACT1 expression level indicates described individuality to suffer from cancer of the stomach.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×